Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
about
Current imaging strategies for the evaluation of uterine cervical cancerClinical practice recommendations for quality of life assessment in patients with gynecological cancerRole of 18F-FDG PET/CT in the carcinoma of the uterus: a review of literatureNew classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical carePremenopausal abnormal uterine bleeding and risk of endometrial cancerThe role of surgery in recurrent endometrial cancer.SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis.Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer.A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasionMistaken identity: endometrial or rectal cancer?Late metastatic endometrial carcinoma at the repair site of an abdominal wall incisional hernia.Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer.Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IBEffect of mTOR inhibitors in nude mice with endometrial carcinoma and variable PTEN expression status.Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.Just how accurate are the major risk stratification systems for early-stage endometrial cancer?A clinically applicable molecular-based classification for endometrial cancers.Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinomaAre preoperative histology and MRI useful for classification of endometrial cancer risk?ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.Immunohistochemical characterisation of molecular subtypes in endometrial cancer.Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase PathwayExosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols.Performance of sentinel lymph node biopsy in high-risk endometrial cancer.Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.Recent and current Phase II clinical trials in endometrial cancer: review of the state of art.EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.Ultrasound in gynecological cancer: is it time for re-evaluation of its uses?Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma.Pathophysiology of heavy menstrual bleeding.Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers.Endometrial cancer: Not your grandmother's cancer.Role of diffusion-weighted MRI in the differential diagnosis of endometrioid and non-endometrioid cancer of the uterus.The role of fulvestrant in endometrial cancer.Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.Endometrial cancer with congenital uterine anomalies: 3 case reports and a literature review.
P2860
Q26751279-76B84E5E-667E-41C7-908A-49B00E06C9DFQ26768706-7086BC06-22C0-46D5-AF46-F36764C8270BQ26851368-712B07E8-D12A-4713-B0F8-8197233AACB8Q28078792-D57D35A1-2AC9-4448-8954-309CEE2A0B37Q30244243-10CD171B-BB19-475E-A161-7686C5D22026Q30249789-EE2583EA-9297-4745-A3E8-3729A9213326Q33582882-40FBE72F-B4E5-4888-9FD0-9C1F9E067FB4Q33648936-4932D31D-1F2C-4301-B7B6-B22FB49A3972Q33683007-325A9FE9-6CAE-4E05-92D0-AE61EEA5E557Q33691535-61F131F4-DD19-49F0-9AB4-9EFD17109791Q33735364-DFE823EF-9B9A-49C3-9A14-EB0F9E329423Q33755309-155C95E5-6595-4839-ABF7-F7B1D1F5CEBBQ33760587-543A2C35-0C3E-4AE9-A078-A7E7997F5AD6Q34306540-327155A4-31B2-44F7-9990-06F3594FEC02Q35121869-F626172C-EB0F-458A-BB2A-734FABB6D7C0Q35125641-BD69BF14-CBA7-47BF-B751-79666117A35CQ35678721-948D2EF7-73DD-44EC-8DB5-243569185363Q35863143-9A718C46-008B-49B3-B9BF-44413825572AQ35887472-22A69DD8-A589-4A5A-9B26-57384453B17CQ36080667-BE46E48B-B553-40CB-8165-BD551B8ECE5FQ36372293-CF48C076-64B7-4D50-A840-ED6847B994ACQ36493409-2D87C5AF-6320-4375-A8E9-D553D4C50032Q36930125-583CA298-1E05-488D-BF3A-E54B32C35B35Q37018155-B393177D-E89D-4FE2-989E-DC429302B7EDQ37086873-1BE2EF3C-1384-4BAD-8DF0-5FB3126DC9F2Q37619708-67C9F1F5-A9E7-4ED0-AA48-AA4FDD9FD940Q38203354-7E7E07CF-F690-4DF3-A7C4-D35666CD92D7Q38476060-236D9E92-F96E-454A-B277-9C6883D187CBQ38484202-DF3FC1D0-02F6-4B7B-B0C4-7733B6C913BAQ38670417-8A20F251-7B95-49EC-AB78-F3F5D517CC78Q38676700-8036F4A3-949F-4DDE-B14D-5F7EB5F11355Q38679531-869EA732-3A20-4901-9240-C372E1CEC934Q38705372-975AED40-7789-4B75-A5B4-8E1635B43998Q38825241-09282B38-FEC2-48A8-AC87-42F5A0BA1C0EQ38852405-1AE1E805-49E2-4866-BC89-1572A56FA7B2Q38963475-F4A08875-5C89-40BF-A5BB-8E772DFC8835Q38970776-DE4B8866-86D3-403C-9AC1-1BFAD20C3A4DQ39036939-DFDC5948-7B6E-48CD-85DD-0E25C5CFEF69Q39069570-4C86C76C-A78D-4607-9F92-A3FEA0252231Q39101014-C01C5FDC-ACB6-46FE-8CE2-0E397C1A6991
P2860
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
description
im September 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2013
@uk
name
Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up
@en
Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up
@nl
type
label
Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up
@en
Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up
@nl
prefLabel
Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up
@en
Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up
@nl
P2093
P2860
P3181
P356
P1433
P1476
Endometrial cancer: ESMO Clini ...... nosis, treatment and follow-up
@en
P2093
A. Colombo
F. Landoni
N. Colombo
S. Carinelli
P2860
P304
P356
10.1093/ANNONC/MDT353
P433
P577
2013-09-27T00:00:00Z